Cargando…
The Role of Iron-Chelating Therapy in Improving Neurological Outcome in Patients with Intracerebral Hemorrhage: Evidence-Based Case Report
Current primary intracerebral hemorrhage (ICH) treatments focus on limiting hematoma volume by lowering blood pressure, reversing anticoagulation, or hematoma evacuation. Nevertheless, there is no effective strategy to protect the brain from secondary injury due to ICH. Excess heme and iron as by-pr...
Autores principales: | Ramadhan, Mochamad Iskandarsyah Agung, Sitanaya, Shierly Novitawati, Hakim, Ariadri Hafian Wulandaru, Ramli, Yetty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058021/ https://www.ncbi.nlm.nih.gov/pubmed/36984454 http://dx.doi.org/10.3390/medicina59030453 |
Ejemplares similares
-
Comparing ultrasonographic optic nerve sheath diameter to head computed tomography scan to predict intracranial pressure elevation
por: Sitanaya, Shierly Novitawati, et al.
Publicado: (2022) -
Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II‐infused mice
por: Wang, Jie, et al.
Publicado: (2021) -
Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
por: Li, Zhe, et al.
Publicado: (2022) -
Ferroptosis and Iron Metabolism after Intracerebral Hemorrhage
por: Sun, Yuanyuan, et al.
Publicado: (2022) -
Intracerebral Hemorrhage Progression Score: A Novel Risk Score to Predict Neurological Deterioration after Intracerebral Hemorrhage
por: Ji, Ruijun, et al.
Publicado: (2022)